Forbes September 3, 2024
Standing next to President Biden at a campaign event last month, Democratic nominee for President, Kamala Harris, celebrated the newly announced price reductions for the first ten prescription medications Medicare negotiated under a provision contained in the Inflation Reduction Act. Harris said she is “proud to have cast the tie-breaking vote that gave Medicare the power to negotiate” drug prices. And now she has reaffirmed her commitment to extend applicability of parts of the law to the commercial insurance sector and build on the Medicare negotiation policy to include more drugs if she becomes President. However, she wouldn’t be able to accomplish these goals on her own. She would need Congressional support.
The Department of Health and Human Services last...
Today's Sponsors
Today's Sponsor